Related Experiment Video
Updated: Jun 27, 2026

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis
Published on: December 30, 2025
Otogenic Lateral Sinus Thrombosis: Controversies and Current Management Strategies
Alexandra Madalina Bizdu-Branovici1, Luana Gherasie1,2, Maria Denisa Zica1,2
1General Medicine, "Carol Davila" University of Medicine and Pharmacy, 8th Eroii Sanitari Boulevard, 050474 Bucharest, Romania.
Otogenic lateral sinus thrombosis (OLST) management requires individualized care. Antibiotics and source control are key, with anticoagulation used selectively based on patient factors.
Area of Science:
- Otolaryngology
- Neurology
- Infectious Diseases
Background:
- Otogenic lateral sinus thrombosis (OLST) is a rare, severe intracranial complication of middle-ear infections.
- Current management, especially anticoagulation, lacks standardized guidelines despite advances in treatment.
- Optimal treatment strategies for OLST remain a subject of clinical debate.
Purpose of the Study:
- To review and synthesize current evidence on the management of otogenic lateral sinus thrombosis (OLST).
- To identify core treatment components and evaluate the role of anticoagulation in OLST.
- To propose a management algorithm for OLST based on available data.
Main Methods:
- Structured narrative review of English-language human studies from January 2015 to January 2025.
- PubMed database search, with subsequent record merging and deduplication.
- Analysis of seven eligible studies involving 140 confirmed OLST patients, excluding case reports and reviews.
Main Results:
- Most studies focused on pediatric populations; clinical presentations were often atypical due to prior antibiotic use.
- MRI/MRV was superior to CT for thrombus assessment and follow-up; antibiotics and surgical source control were standard treatments.
- Anticoagulation, typically with low molecular weight heparin, was inconsistently applied, with varied indications and durations.
Conclusions:
- Individualized OLST management is crucial, considering disease severity, thrombus extent, and patient risk factors.
- Essential treatments include antibiotics and source control; anticoagulation should be selectively considered.
- A proposed management algorithm requires validation through prospective multicenter studies.
Related Concept Videos
Mitral Stenosis III: Medical Management
Brain Abscess l: Introduction
Venous Thrombosis III: Interprofessional Care
Tonsillitis II: Management
Endocarditis III: Medical Management
Mitral Regurgitation III: Medical Management